NOW
Kava Kava Extract 250 mg
Brand context
Catalog
4,981
products
With avoid flag
2
products
FDA recalls
0
history
CAERS
48
reports
Clean labelObjective label signals
Flagged excipients
0
none
FDA recalls
0
no recall history
CAERS reports
37
FDA consumer events
Certifications
0
none recorded
No authority-flagged excipients or recalls. · Every flag below links to the authority's published citation.
NIH LiverTox
1 ingredient with hepatotoxicity classification
Worst severity: Category A
- Kava kavaCategory A
LiverTox Category A (well-established cause). Severe idiosyncratic hepatitis including liver failure / transplant. Banned or restricted in Germany, UK, France, Switzerland.
LiverTox →
Supplement Facts
2 active ingredients| Ingredient | Amount | % DV |
|---|---|---|
| Kava Kava extract Kava kavaherb LiverTox A | 250 mg | — |
| Eleuthero Eleuthero RootherbUNII · ZQH6VH092Z | 100 mg | — |
FDA CAERS · adverse event context
37
consumer-submitted adverse event reports filed with the FDA CFSAN Adverse Event Reporting System mentioning this product or its brand.
CAERS reports are unverified consumer submissions — not adjudicated causality. Large well-known brands accumulate proportionally more reports simply due to broader use. About CAERS →
Other ingredients
Gelatin · Cellulose · Magnesium Stearate · Silica
Chemically equivalent
Same formula, different brand
Products with identical sorted (ingredient, amount) tuples.